Clinical Trial Supplies 2016

 

2nd Annual Symposium

 

20 & 21 of October 2016

 

Golden Tulip Brussels Airport Hotel, Brussels, Belgium

 

• How to ensure and maintain a successful contractor relationship

 

• How Data and risk-based distribution strategy can lower risk of temperature excursions

 

• What is the impact of the EU GDP guidelines?

 

• How to understand the behavioral traits and styles of your Business partners to solidify the relationship

 

• Integrating GDP Chapter 9 principle 9.1 in supply considerations into the supply chain to safeguard shipments and deliver timely trial results

 

• Discussing new paradigms in adaptive supply chain design to ensure a consistent protocol supply

 

• Vendor selection criteria for clinical trial supply outsourcing

 

• Developing effective Just in Time Manufacturing (JIM) strategies for Phase I studies to meet requirements when combining different protocols

 

• Adopting JIT labeling for clinical studies to reduce overage of CTM and lower costs of bulk shipping

 

• How to use the Clinical Trial Supply Network to support new initiatives and innovations

 

• Clinical Trials in an environment in Russia, Ukraine and Belarus: Has the industry changed since sanctions?

 

• What are the challenges of clinical trial supply sourcing globally (with reference to emerging markets?) – Providing a case study

 

• Are there any distribution challenges to international sites? (Reference to Latin America, India and Asia-Pacific countries)

 

• Exploring the utilisation of Systems, Applications & Products (SAP) technology for end-to-end clinical trial supply management

 

• How to investigate the best form of ambient control in compliance with EU GDP Directive

 

• How to improve the overall efficiency of the Supply Chain

 

• Analysing recent Innovations in clinical supplies

 

• Challenges of Clinical Trial Supply Sourcing Globally, specifically in emerging markets

 

• Best Practices for Managing Clinical Supplies in an Evolving Marketplace

 

• Biologics and Clinical Trials – What are the challenges?

 

• How to enhance distribution practices through resource pooling

 

• The need and importance of more detailed stability data in order to maximise product safety and reduce wastage from poor shipment conditions

 

• Outlining challenges for the use of marketed products in clinical trials

 

• Case Study: (Small to Midsize Perspective): Clinical Trial Material manufacturing, packaging and release procedures

 

• Randomisation & Trial Supply Management (RTSM) Vs Artificial Intelligence (AI)

 [Human Vs Machine] in clinical supply chain

 

• The best outsourcing strategy for your company to enhance communication of study teams both internally and externally through your service-providers

 

• Discussing electronic solutions for clinical trial IP management

 

• Discussing apps and technology in clinical trials: How to improve study efficiency and patient compliance

 

• Integrating supplies management within a unified technology platform approach; an adaptive trials focus

 

 

Speaker Topics

 

Only for:

Pharma/Biopharma/Biotech Companies

 

 

 

 

DOWNLOAD THE FULL AGENDA

An event by Pharma Dialogue, the Healthcare division of